anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

173,941-174,000 of 319,975

filter-aware
09
The slide uses a waterfall chart to bridge the gap between 2020 and 2021 EBITDA, followed by a detailed EBT reconciliation table.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Rising SuccessLoop · Before After1 hit
10
The chart shows the reconciliation of EBT to Free Cash Flow, highlighting key drivers like D&A, Working Capital, and Investing Activities.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Rising SuccessLoop · Before After1 hit
11
The waterfall chart reconciles the cash balance from 31-Dec-20 to 31-Dec-21.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Rising Success1 hit
12
Includes a callout box regarding quarterly seasonality and specific vehicle production focus.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Rising Success1 hit
13
Features an Aston Martin DBX SUV as the primary visual element.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Rising Success1 hit
14
The slide uses a six-column layout to categorize operational and strategic progress.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Rising Success1 hit
15
The slide uses a central image of an Aston Martin SUV with four surrounding icons representing strategic pillars.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · The Breakthrough1 hit
16
The slide uses an Aston Martin F1 car as a visual anchor for brand identity.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · The Breakthrough1 hit
17
The slide uses a background image of cars on a road to visually represent the 'journey' and 'portfolio' themes.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · The Breakthrough1 hit
18
Includes quotes from EVO, Autocar, Top Gear, Mr. JWW, and Carwow.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · The Breakthrough1 hit
19
The slide uses a background image of leather stitching, likely referencing the brand's craftsmanship.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · The Breakthrough1 hit
20
The slide uses a background image of a craftsman working on a luxury car seat to reinforce the 'performance-led' and 'ultra-luxury' messaging.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · The Breakthrough1 hit
21
The slide uses a 'verb-led' strategic framework (Create, Expand, Deliver, Strengthen, Generate).Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · The Breakthrough1 hit
22
Aston Martin Lagonda | Results Presentation Deck | 28 slidesAston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
23
Aston Martin Lagonda | Results Presentation Deck | 28 slidesAston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
24
The slide presents a comprehensive financial overview including P&L, cash flow, and debt metrics.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
25
Includes three distinct tables: Income Statement, Cash Flow, and EBITDA reconciliation.Aston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
26
Aston Martin Lagonda | Results Presentation Deck | 28 slidesAston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
27
Aston Martin Lagonda | Results Presentation Deck | 28 slidesAston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
28
Aston Martin Lagonda | Results Presentation Deck | 28 slidesAston Martin Lagonda | Results Presentation Deck | 28 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
01
Slide 1
Includes company logo and date.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
02
AstraZeneca | Investor Day Presentation Deck | 35 slidesAstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
03
AstraZeneca | Investor Day Presentation Deck | 35 slidesAstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
04
AstraZeneca | Investor Day Presentation Deck | 35 slidesAstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
05
Slide 1 of a presentation deck.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
06
The diagram uses a circular flow to categorize drug mechanisms (Immune engagers, Cell therapy, Oncolytic virus, Immuno-oncology, DNA damage response, Antibody drug conjugates, Radioimmuno-conjugates, Nanomedicines, Epigenetics).AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations Beat · Interest1 hit
07
The slide categorizes the 19 abstracts into oral, mini-oral, and poster presentations, and lists three specific clinical trial highlights.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations Beat · Interest1 hit
08
The slide combines a Kaplan-Meier survival curve with a biological process flow diagram to support the clinical efficacy findings.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
09
AstraZeneca | Investor Day Presentation Deck | 35 slidesAstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
10
The slide uses a standard clinical trial flow diagram (CONSORT-style).AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
11
The slide demonstrates that the two study arms are well-balanced at baseline, which is a standard requirement for clinical trial validity.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
12
Clinical trial data presentation; includes hazard ratio and median rPFS comparison.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
13
The slide uses a Kaplan-Meier plot to visualize time-to-event data for a clinical trial.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
14
The slide uses a forest plot to visualize HRs and 95% CIs for multiple clinical subgroups.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
15
Clinical trial data presentation (Kaplan-Meier plot).AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
16
Clinical trial data showing hazard ratios and median survival times for secondary endpoints.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
17
The slide highlights specific safety metrics including AE grades, death, and treatment modifications.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
18
SMQ = Standardised MedDRA Query; CT = computerised tomography.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
19
The chart uses a diverging bar structure to compare two treatment arms.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
20
The slide uses color-coded text (orange) to emphasize key clinical findings.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
21
The slide features a stylized silhouette of a human figure with internal biological/molecular imagery.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
22
The slide uses a matrix-like structure to segment patients by disease stage (Hormone sensitive vs Castration resistant) and prior treatment exposure (NHA naive vs NHA experienced).AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
23
The slide uses a three-column layout to frame the problem (left), the study design (middle), and the clinical outcomes (right).AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations Beat · Agitate (Make it worse)1 hit
24
The slide uses a patient image to humanize the clinical data. The comparison focuses on the delta (8.2m) between control/standard and experimental arms.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
25
The slide uses a flow-chart style diagram to segment the patient population and position the Lynparza + abiraterone combination.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
26
Slide 4 of the presentation deck.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
27
The slide presents two distinct clinical data sets: a summary table for the BAYOU trial and a spider plot for the U105 trial.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
28
The slide features a stylized silhouette of a human head and torso with biological/molecular imagery inside.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
29
AstraZeneca | Investor Day Presentation Deck | 35 slidesAstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
30
AstraZeneca | Investor Day Presentation Deck | 35 slidesAstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
31
AstraZeneca | Investor Day Presentation Deck | 35 slidesAstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
32
Includes a Kaplan-Meier curve for rPFS and a forest plot for HR by HRRm subgroup.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
33
Data presented as stacked bar charts showing CR, PR, SD, and PD components.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
34
The chart shows overlapping confidence intervals, supporting the conclusion of comparability.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
35
AstraZeneca | Investor Day Presentation Deck | 35 slidesAstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations 1 hit
01
Slide 1
AstraZeneca | Results Presentation Deck | 39 slidesAstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit
02
AstraZeneca | Results Presentation Deck | 39 slidesAstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit
03
AstraZeneca | Results Presentation Deck | 39 slidesAstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit
04
AstraZeneca | Results Presentation Deck | 39 slidesAstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit
05
AstraZeneca | Results Presentation Deck | 39 slidesAstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit